Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

Bleeds on Anticoagulants for A-Fib Can Unveil Occult Cancers

Caitlin E. Cox

November 06, 2020

News Conference News TCT 2020

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

Caitlin E. Cox

October 18, 2020

News Industry News

CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI

October 17, 2020

Presentation TCT 2020

COBRA-REDUCE: Randomized Trial of COBRA PzF Stenting to REDUCE Duration of Triple Therapy

Presenter: Robert A. Byrne

October 17, 2020

News Daily News

More Insights Into AAA Genetics Spur New Questions on Screening

Caitlin E. Cox

September 29, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

Caitlin E. Cox

September 14, 2020

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Daily News

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

Yael L. Maxwell

August 27, 2020

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Conference News SCCT 2020

Biggest Barriers to Cardiac CT? Old Myths, Fair Payment, and De-adoption

Yael L. Maxwell

July 22, 2020

News Conference News ACC 2020

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

Todd Neale

April 03, 2020

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

News Conference News ACC 2020

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

Michael O'Riordan

March 28, 2020

News Conference News ACC 2020

More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA

Michael O'Riordan

March 28, 2020

News Daily News

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

Todd Neale

March 16, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

Advertisement

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Bleeds on Anticoagulants for A-Fib Can Unveil Occult Cancers

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI

COBRA-REDUCE: Randomized Trial of COBRA PzF Stenting to REDUCE Duration of Triple Therapy

More Insights Into AAA Genetics Spur New Questions on Screening

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Biggest Barriers to Cardiac CT? Old Myths, Fair Payment, and De-adoption

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content